G1 EXECUTION SERVICES, LLC enters ACHILLION PHARMACEUTICALS INC with 14.13M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/30/2020ACC: 0001104659-20-008790
10% Owner
Since Jan 2020
14.13M
Baseline shares
100% direct
14.13M
Direct ownership
2 positions
486K
Derivative underlying
5 instruments
2
Security positions
All direct
Non-Derivative Holdings2
Common Stock
DirectShares owned10.92K
Common Stock
DirectShares owned14.12M
Total
14.13M direct14.13M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10.92K | Direct |
| Common Stock | 14.12M | Direct |
| Total | 14.13M | 14.13M direct |
Derivative Holdings5
Call Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
454.90K
Shares owned
N/A
Exercise price
7.00
Expiration
—
Exercise window
—
Total Return Swap
DirectUnderlying security
Common Stock
Underlying shares
8K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total Return Swap
DirectUnderlying security
Common Stock
Underlying shares
7.10K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total Return Swap
DirectUnderlying security
Common Stock
Underlying shares
8K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total Return Swap
DirectUnderlying security
Common Stock
Underlying shares
8K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
486K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Call Option (right to buy) Direct | Common Stock | 7.00 | — | — | 454.90K | N/A |
| Total Return Swap Direct | Common Stock | — | — | 8K | N/A | |
| Total Return Swap Direct | Common Stock | — | — | 7.10K | N/A | |
| Total Return Swap Direct | Common Stock | — | — | 8K | N/A | |
| Total Return Swap Direct | Common Stock | — | — | 8K | N/A | |
| Total | 486K | 0.00 | ||||